Volume 62, Pages S36-S41 (December 2002)

Slides:



Advertisements
Similar presentations
Volume 54, Pages S135-S139 (December 1998)
Advertisements

Volume 56, Pages S238-S241 (July 1999)
Copyright © 2011 American Medical Association. All rights reserved.
Volume 54, Issue 4, Pages (October 1998)
Plasma sodium and hypertension
Volume 56, Pages S95-S98 (November 1999)
Epidemiology of diabetic nephropathy in Spain
Shannon D. Sullivan, M. D. , Philip M. Sarrel, M. D. , Lawrence M
Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation  Anil K. Bidani, M.D., Karen A. Griffin,
Volume 64, Pages S27-S32 (October 2003)
Volume 54, Pages S86-S91 (December 1998)
Francesco Locatelli, Lucia Del Vecchio, Simeone Andrulli, Sara Colzani 
Volume 93, Issue 1, Pages (January 2018)
Progression of renal failure and hypertensive nephrosclerosis
End point Net change with soy supplements vs control (95% CI) p
Francesco Paolo Schena  Kidney International 
Volume 69, Pages S11-S15 (April 2006)
Volume 70, Pages S21-S25 (December 2006)
Volume 57, Pages S32-S37 (April 2000)
Volume 56, Issue 4, Pages (October 1999)
Prediction of hypertension in chronic hemodialysis patients
Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients  Tatsuya Shoji, Yoshiharu Tsubakihara,
A new era in phosphate binder therapy: What are the options?
Volume 81, Issue 3, Pages (February 2012)
Volume 80, Issue 10, Pages (November 2011)
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension  A. Davenport, C. Cox, R. Thuraisingham  Kidney.
Volume 91, Issue 5, Pages (May 2017)
Blood pressure targets in hemodialysis patients
Volume 67, Pages S63-S68 (January 2005)
Volume 72, Issue 12, Pages (December 2007)
New insights in uremic toxins
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Nephrology in Latin America, with special emphasis on Brazil
Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia 
AGEs in foods: Do they play a role in uremia?
The kidney, a cardiovascular risk marker, and a new target for therapy
Counteracting progression of renal disease: A look into the future
Volume 81, Issue 4, Pages (February 2012)
Volume 54, Pages S135-S139 (December 1998)
Volume 73, Issue 8, Pages (April 2008)
Volume 62, Pages S47-S52 (December 2002)
Volume 54, Issue 4, Pages (October 1998)
Volume 67, Pages S15-S19 (January 2005)
Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors  Barry M. Brenner, Joann Zagrobelny 
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study1  Robert N. Foley, Charles A. Herzog, Allan J.
Carmine Zoccali, Francesca Mallamaci  Kidney International 
The course of the remnant kidney model in mice
Volume 68, Issue 5, Pages (November 2005)
Volume 56, Pages S238-S241 (July 1999)
Clinical and biochemical correlates of starting “daily” hemodialysis
Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension  Julian Segura, Carlos Campo, Luis M. Ruilope  Kidney.
Volume 68, Pages S98-S102 (December 2005)
Charles A. Herzog  Kidney International 
Volume 75, Issue 1, Pages (January 2009)
Renal replacement therapy in Latin America
Importance of blood pressure control in hemodialysis patient survival
Volume 62, Issue 6, Pages (December 2002)
Strategies for iron supplementation: Oral versus intravenous
The International Pediatric Peritonitis Registry: Starting to walk
Evaluation of the Losartan in Hemodialysis (ELHE) Study
Renal vascular disease in the elderly
Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis  Karl-Georg Fischer, M.D., Andreas van.
Selective estrogen receptor modulators in chronic renal failure
Volume 57, Issue 2, Pages (October 2000)
Volume 73, Issue 11, Pages (June 2008)
Volume 62, Pages S2-S7 (December 2002)
Volume 54, Pages S112-S119 (December 1998)
Antonio Piccoli, Luana Pillon  Kidney International 
Presentation transcript:

Volume 62, Pages S36-S41 (December 2002) Angiotensin II type 1 receptor blockade to control blood pressure in postmenopausal women: Influence of hormone replacement therapy  Francisco Fernández-Vega, José Abellán, Onofre Vegazo, Soledad García De Vinuesa, José Carlos Rodríguez, Benito Maceira, Saturnino Sanz De Castro, Roberto Robles Nicolás, José Luño  Kidney International  Volume 62, Pages S36-S41 (December 2002) DOI: 10.1046/j.1523-1755.62.s82.8.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Course of the mean (A) systolic and (B) diastolic blood pressure (SBP and DBP) values on the different follow-up visits of the study. (C) Time course of the mean percentage SBP (♦) and DBP (▪) control values and global BP (▴) control (SBP ≤140 mm Hg and/or DBP ≤90 mm Hg) in the course of the 24 weeks of follow-up (means ± standard deviation, SD). *P < 0.01, †P < 0.01 vs. Visit 1 and Visit 2. Kidney International 2002 62, S36-S41DOI: (10.1046/j.1523-1755.62.s82.8.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Time course of the mean global percentage BP control (A, SBP ≤140 mm Hg and/orB, DBP ≤90 mm Hg) throughout the 24 weeks of follow-up of the study, in the subgroups of patients with and without hormone replacement therapy (HRT). Data are means ± standard deviation (SD). Symbols are: (♦) with hydrochlorothiazide (HCTZ), N = 122; (▪) without HCTZ, N = 265. *P < 0.01 in both subgroups. In (C), the odds ratio = 1.8, 95% CI = 1.04-3.05, and P < 0.03. Kidney International 2002 62, S36-S41DOI: (10.1046/j.1523-1755.62.s82.8.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Blood pressure control in postmenopausal women with HRT (•) or without HRT (▪) during successive visits. Kidney International 2002 62, S36-S41DOI: (10.1046/j.1523-1755.62.s82.8.x) Copyright © 2002 International Society of Nephrology Terms and Conditions